Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists

Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists

US Patent 10294303 · Granted May 21, 2019

Estimated economic value: $223,841,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating or ameliorating metabolic disorders using antagonistic bindin2025
Antibody-drug conjugates targeting folate receptor alpha and methods of use2025
Method of treating or ameliorating metabolic disorders using binding proteins fo2025
Method of treating or ameliorating metabolic disorders using binding proteins fo2025
Method of treating or ameliorating metabolic disorders using binding proteins fo2025
Bispecific antibodies with cleavable C-terminal charge-paired tags2025
Anti-ASGR-1 monoclonal inhibitory antibodies2025
MAGEB2 binding constructs2025
Anti-CCR8 antibodies and uses thereof2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025